You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

SODIUM LACTATE 1 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Sodium Lactate 1, and when can generic versions of Sodium Lactate 1 launch?

Sodium Lactate 1 is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in SODIUM LACTATE 1 is sodium lactate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium lactate profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for SODIUM LACTATE 1?
  • What are the global sales for SODIUM LACTATE 1?
  • What is Average Wholesale Price for SODIUM LACTATE 1?
Summary for SODIUM LACTATE 1
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:SODIUM LACTATE 1 at DailyMed
Drug patent expirations by year for SODIUM LACTATE 1

US Patents and Regulatory Information for SODIUM LACTATE 1

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER sodium lactate INJECTABLE;INJECTION 020004-001 Apr 21, 1992 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.